Showing results (331-340 of 991) with videos related to
Sort By:
Pageof 100
Assay and Drug Development Technologies|January 28, 2006
Optimization, application, and interpretation of lactate dehydrogenase measurements in microwell determination of cell number and toxicityHubert Th Wolterbeek, Astrid J G M van der MeerAssay and Drug Development Technologies|December 7, 2007
A three-stage experimental strategy to evaluate and validate an interplate IC50 formatDaniel J Rodrigues, Richard Lyons, Philip Laflin, et al.Assay and Drug Development Technologies|September 11, 2004
Rapid structure-activity and selectivity analysis of kinase inhibitors by BioMAP analysis in complex human primary cell-based modelsEric J Kunkel, Ivan Plavec, Dat Nguyen, et al.Assay and Drug Development Technologies|April 20, 2004
Characterization of fatty acid synthase activity using scintillation proximityDonna R Weiss, J Fraser GlickmanAssay and Drug Development Technologies|April 20, 2004
Multiplexed screening assay for mRNA combining nuclease protection with luminescent array detectionRalph R Martel, Ihab W Botros, Matthew P Rounseville, et al.Assay and Drug Development Technologies|April 20, 2004
Development of a high-throughput assay for two inositol-specific phospholipase Cs using a scintillation proximity formatMichael E Bembenek, Sadhana Jain, Andrea Prack, et al.Assay and Drug Development Technologies|April 20, 2004
High-throughput screening with immobilized metal ion affinity-based fluorescence polarization detection, a homogeneous assay for protein kinasesElma E M G Loomans, Antoon M van Doornmalen, Jesse W Y Wat, et al.Assay and Drug Development Technologies|April 20, 2004
HTS compatible assay for antioxidative agents using primary cultured hepatocytesFrank Gaunitz, Kerstin HeiseAssay and Drug Development Technologies|April 20, 2004
A one-arm homologous recombination approach for developing nuclear receptor assays in somatic cellsSohail A Qureshi, Pam Sanders, Karin Zeh, et al.Assay and Drug Development Technologies|April 20, 2004
A beta-lactamase-dependent Gal4-estrogen receptor beta transactivation assay for the ultra-high throughput screening of estrogen receptor beta agonists in a 3456-well formatNorbert T Peekhaus, Marc Ferrer, Tina Chang, et al.Pageof 100